Showing results (21-30 of 324) with videos related to
Sort By:
Pageof 33
Trends in Immunology|October 4, 2012
Advances in the development of cancer immunotherapiesJianjun Gao, Chantale Bernatchez, Padmanee Sharma, et al.Cancer Research|June 5, 2003
CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cellsRéjean Lapointe, Angélique Bellemare-Pelletier, Franck Housseau, et al.Journal of Translational Medicine|February 2, 2011
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 programJames M Balwit, Patrick Hwu, Walter J Urba, et al.Medicine|January 31, 2016
GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case ReportSapna P Patel, Dae Won Kim, Carol L Lacey, et al.Cancer Cell|July 19, 2024
Tumor-infiltrating lymphocytes: A new hopeAmod A Sarnaik, Patrick Hwu, James J Mulé, et al.Cancer Treatment and Research|November 26, 2015
Novel Treatments in Development for MelanomaChantale Bernatchez, Zachary A Cooper, Jennifer A Wargo, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitroYufeng Li, Shujuan Liu, Jessica Hernandez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapyJeffrey Weber, Michael Atkins, Patrick Hwu, et al.Oncotarget|May 7, 2016
Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2Geok Choo Sim, Sheng Wu, Lei Jin, et al.Annual Review of Medicine|October 25, 2012
Harnessing the power of the immune system to target cancerGregory Lizée, Willem W Overwijk, Laszlo Radvanyi, et al.Pageof 33